Hepion Pharmaceuticals In...

0.29
0.01 (2.11%)
At close: Apr 24, 2025, 3:59 PM
0.29
-0.03%
After-hours: Apr 24, 2025, 07:04 PM EDT

Hepion Pharmaceuticals Statistics

Share Statistics

Hepion Pharmaceuticals has 10.98M shares outstanding. The number of shares has increased by -89.82% in one year.

Shares Outstanding 10.98M
Shares Change (YoY) -89.82%
Shares Change (QoQ) -89.99%
Owned by Institutions (%) 9.38%
Shares Floating 10.92M
Failed to Deliver (FTD) Shares -
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 199.81K, so 18.5% of the outstanding shares have been sold short.

Short Interest 199.81K
Short % of Shares Out 18.5%
Short % of Float 18.5%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -0.22 and the forward PE ratio is null. Hepion Pharmaceuticals's PEG ratio is 0.

PE Ratio -0.22
Forward PE n/a
PS Ratio 0
Forward PS n/a
PB Ratio -1.55
P/FCF Ratio -0.16
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Hepion Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.51, with a Debt / Equity ratio of -1.56.

Current Ratio 0.51
Quick Ratio 0.51
Debt / Equity -1.56
Debt / EBITDA -0.15
Debt / FCF -0.16
Interest Coverage 15.51

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-599.66K
Employee Count 22
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 2.97M
Effective Tax Rate -18.37%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 1.8, so Hepion Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.8
52-Week Price Change null%
50-Day Moving Average 3.07
200-Day Moving Average 24.32
Relative Strength Index (RSI) 21.09
Average Volume (20 Days) -

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -19.35M
Net Income -13.19M
EBITDA -19.35M
EBIT -17.41M
Earnings Per Share (EPS) -107.35
Full Income Statement

Balance Sheet

The company has 406.41K in cash and 2.9M in debt, giving a net cash position of -2.49M.

Cash & Cash Equivalents 406.41K
Total Debt 2.9M
Net Cash -2.49M
Retained Earnings -237.82M
Total Assets 1.61M
Working Capital -1.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.22M and capital expenditures 0, giving a free cash flow of -18.22M.

Operating Cash Flow -18.22M
Capital Expenditures 0
Free Cash Flow -18.22M
FCF Per Share -148.23
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HEPA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for HEPA.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Mar 18, 2025. It was a backward split with a ratio of 1:50.

Last Split Date Mar 18, 2025
Split Type backward
Split Ratio 1:50

Scores

Altman Z-Score -238.73
Piotroski F-Score 1